| Original language | English |
|---|---|
| Pages (from-to) | 741-743 |
| Number of pages | 3 |
| Journal | BJU International |
| Volume | 130 |
| Issue number | 6 |
| Early online date | 20 Sept 2022 |
| DOIs | |
| Publication status | Published - Dec 2022 |
Low-grade prostate cancer should still be labelled cancer
Kenneth A. Iczkowski*, Mariel Molina, Lars Egevad, David G. Bostwick, Geert J. L. H. van Leenders, Francisco G. La Rosa, Theodorus van der Kwast, Daniel M. Berney, Andrew J. Evans, Thomas M. Wheeler, Katia R. M. Leite, Hemamali Samaratunga, John Srigley, Murali Varma, Toyonori Tsuzuki, Marshall Scott Lucia, Elward David Crawford, Richard G. Harris, Philip Stricker, Nathan Lawrentschuk
*Corresponding author for this work
- Medical College of Wisconsin
- Karolinska Institutet
- Bostwick Labs
- University of Colorado Anschutz Medical Campus
- Barts Health NHS Trust
- Mackenzie Health
- Baylor College of Medicine
- Universidade Federal de São Paulo
- Griffith University Queensland
- Toronto Western Hospital
- Cardiff Metropolitan University
- Aichi Medical University
- University of California at San Diego
- UroPartners
- St Vincents Private Hospital & Clinic
- Melbourne School of Population and Global Health
- Sydney Adventist Hospital
- Atlantic Urol Clin
- Wesley Hospital
- The Sahlgrenska Academy at the University of Gothenburg
- Royal Brisbane and Women's Hospital
- Indiana University-Purdue University Indianapolis
- University of Otago
Research output: Contribution to journal › Editorial › Academic › peer-review
10
Citations
(Web of Science)